Patent · US Active

Allergen desensitization method

US10022439B2 · kind B2 · utility

4Cited by

45References

14Claims

0Family size

Assignee

DBV TECHNOLOGIES · FR

Inventors

Christophe Dupont · Clamart, FR
Pierre-Henri Benhamou · Paris, FR
Bertrand Dupont · Aix-en-Provence, FR

Key dates

Filing date	Dec 1, 2016
Grant date	Jul 17, 2018
Priority date	—
Expiry date	Dec 1, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/545
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.